AVTX position history
The shares of Avalo Therapeutics (AVTX) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 916,000 shares, $14M, 0.08% of portfolio, New
- 2026 Q2: 2,498,000 shares, $46M, 0.21% of portfolio, Add +172.7%
- 2026 Q3: 3,974,000 shares, $61M, 0.26% of portfolio, Add +59.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|